Abstract
Biomarkers could be used for evaluation of myocardial fibrosis. The most studied are the procollagen peptides, the matrix metalloproteinases, ST-2 and galectin-3. We have observed the best evidence in heart failure patients. Trials are conducted also in atrial fibrillation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
